Those who invested in Geron (NASDAQ:GERN) three years ago are up 188%

Some Geron Corporation (NASDAQ:GERN) shareholders are probably rather concerned to see the share price fall 32% over the last three months. But in three years the returns have been great. Indeed, the share price is up a very strong 188% in that time. After a run like that some may not be surprised to see prices moderate. The fundamental business performance will ultimately dictate whether the top is in, or if this is a stellar buying opportunity.

Now it's worth having a look at the company's fundamentals too, because that will help us determine if the long term shareholder return has matched the performance of the underlying business.

Check out our latest analysis for Geron

Geron isn't currently profitable, so most analysts would look to revenue growth to get an idea of how fast the underlying business is growing. When a company doesn't make profits, we'd generally hope to see good revenue growth. That's because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size.

In the last 3 years Geron saw its revenue grow at 119% per year. That's much better than most loss-making companies. Along the way, the share price gained 42% per year, a solid pop by our standards. This suggests the market has recognized the progress the business has made, at least to a significant degree. Nonetheless, we'd say Geron is still worth investigating - successful businesses can often keep growing for long periods.

The image below shows how earnings and revenue have tracked over time (if you click on the image you can see greater detail).

earnings-and-revenue-growth
NasdaqGS:GERN Earnings and Revenue Growth February 5th 2025

You can see how its balance sheet has strengthened (or weakened) over time in this free interactive graphic.

Advertisement

A Different Perspective

It's good to see that Geron has rewarded shareholders with a total shareholder return of 54% in the last twelve months. That gain is better than the annual TSR over five years, which is 18%. Therefore it seems like sentiment around the company has been positive lately. Given the share price momentum remains strong, it might be worth taking a closer look at the stock, lest you miss an opportunity. You could get a better understanding of Geron's growth by checking out this more detailed historical graph of earnings, revenue and cash flow.

For those who like to find winning investments this free list of undervalued companies with recent insider purchasing, could be just the ticket.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NasdaqGS:GERN

Geron

A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.

Undervalued with high growth potential.

Advertisement

Weekly Picks

ST
stuart_roberts
UG logo
stuart_roberts on Upside Gold ·

An Undervalued 3.3Moz Gold Project in Canada

Fair Value:CA$5.0776.3% undervalued
83 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative
YA
SOFI logo
Yang_ on SoFi Technologies ·

SoFi Technologies: The Apex Aggregator and the Infrastructure of the Modern Financial System

Fair Value:US$22.9820.4% undervalued
9 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative
KO
CSL logo
Kouj on CSL ·

CSL: The Dip Is the Opportunity

Fair Value:AU$1556.7% undervalued
6 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative
GA
DHT logo
GavrielH on DHT Holdings ·

DHT Holdings, inc: Strait of Hormuz Risk Amidst US-Israel vs Iran Tensions Spikes VLCC Rates.

Fair Value:US$3648.3% undervalued
2 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative

Updated Narratives

AS
BFIT logo
ashwin3407 on Basic-Fit ·

Basic-Fit: Why the Market Is Mispricing Europe’s Largest Low-Cost Gym Operator

Fair Value:€68.4756.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
CF
CFFF
DRO logo
CFFF on DroneShield ·

DroneShield's Growth Will Drive Revenue Up by 25.39% Amidst New Success

Fair Value:AU$1.36195.6% overvalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
VE
Vestra
PATH logo
Vestra on UiPath ·

UiPath Inc. (PATH): Agentic AI Pivot and Milestone Profits Set the Stage for Q4 Results

Fair Value:US$19.6841.1% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

KA
NU logo
kabz2342 on Nu Holdings ·

Nu holdings will continue to disrupt the South American banking market

Fair Value:US$64.376.9% undervalued
51 users have followed this narrative
3 users have commented on this narrative
27 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$59631.9% undervalued
1306 users have followed this narrative
2 users have commented on this narrative
10 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$253.0227.0% undervalued
1102 users have followed this narrative
7 users have commented on this narrative
34 users have liked this narrative